Please login to the form below

Not currently logged in
Email:
Password:

Andrew Gengos joins ImmunoCellular as CEO

Will lead company as it initiates phase II trials investigating brain tumour vaccine

ImmunoCellular Andre GengosCancer specialist ImmunoCellular Therapeutics has appointed Andrew Gengos as president and CEO.

Gengos joins from Neuraltus Pharmaceuticals, where he also served as president and CEO, and becomes the permanent replacement for Dr Manish Singh who left the company in August 2012 to "pursue other opportunities".

Since August, ImmunoCellular's founder and chief scientific officer Dr John Yo has served as interim CEO.

Gengos joins at an important time for ImmunoCellular, with the company having recently commenced a phase II trial investigating its lead product candidate ICT-107, a potential cell-based vaccine for glioblastoma brain tumours.

ImmunoCellular will benefit from Gengos's experience in neuroscience during his time at Neuraltus, which specialises in therapies for neurodegenerative diseases, such as amyotrophic lateral sclerosis and Parkinson's disease.

“Joining ImmunoCellular is an extraordinary opportunity to help build a leading biopharmaceutical company with the potential to transform the treatment of cancer,” said Gengos. “I believe that the company's immunotherapy platform that targets both cancer cells and cancer stem cells represents a promising and innovative medical breakthrough.”

Prior to joining Neuraltus spent more than seven years at Amgen, holding such positions as VP, strategy and corporate development.

He has also spent time at Dynavax Technologies, Chiron Corporation and McKinsey & Company.

5th December 2012

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics